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ABSTRACT
Objectives: We compared the effectiveness of the
Gold Standard Programme (a comprehensive smoking
cessation intervention commonly used in Denmark)
with other face-to-face smoking cessation programmes
in Denmark after implementation in real life, and we
identified factors associated with successful quitting.
Design: Prospective cohort study.
Setting: A total of 423 smoking cessation clinics from
different settings reported data from 2001 to 2013.
Participants: In total, 82 515 patients were registered.
Smokers ≥15 years old and attending a programme
with planned follow-up were included. Smokers who
did not want further contact, who intentionally were
not followed up or who lacked information about the
intervention they received were excluded. A total of
46 287 smokers were included.
Interventions: Various real-life smoking cessation
interventions were identified and compared: The Gold
Standard Programme, Come & Quit, crash courses,
health promotion counselling (brief intervention) and
other interventions.
Main outcome: Self-reported continuous abstinence
for 6 months.
Results: Overall, 33% (11 184) were continuously
abstinent after 6 months; this value was 24% when
non-respondents were considered smokers. The
follow-up rate was 74%. Women were less likely to
remain abstinent, OR 0.83 (CI 0.79 to 0.87). Short
interventions were more effective among men. After
adjusting for confounders, the Gold Standard
Programme was the only intervention with significant
results across sex, increasing the odds of abstinence
by 69% for men and 31% for women. In particular,
compliance, and to a lesser degree, mild smoking,
older age and not being disadvantaged were associated
with positive outcomes for both sexes. Compliance
increased the odds of abstinence more than 3.5-fold.
Conclusions: Over time, Danish smoking cessation
interventions have been effective in real life.
Compliance is the main predictor of successful
quitting. Interestingly, short programmes seem to
have relatively strong effects among men, but the
absolute numbers are very small. Only the
comprehensive Gold Standard Programme works
across sexes.
INTRODUCTION
Tobacco is the most damaging and prevent-
able lifestyle factor affecting public health
globally and nationally.1 2 Its harmful effects
are well documented.3 Globally, the WHO
estimates that ∼6 million people die from
smoking-related diseases yearly.1 Many coun-
tries, including Denmark, have introduced
restrictive laws and strategies to reduce
smoking.4 More than 12 800 people in
Denmark die as a consequence of smoking
annually, corresponding to 1 in 4 deaths.4
Over the past 15–20 years, many initiatives
have been launched to help smokers quit.
Smoking cessation programmes are one of
many initiatives. Additionally, tobacco control
Strengths and limitations of this study
▪ This study was based on a large cohort of
smokers from all regions and settings in
Denmark; 46 287 smokers were included in the
study, and the follow-up rate was high (74%).
▪ The study was based on routinely collected
health data with high completeness and preci-
sion, and the implications were considered
minimal, as the research question was in line
with the purposes of the database.
▪ Confounding effects were carefully considered
and adjusted for, but we cannot exclude the
possibility of residual confounding from other
potential confounders, such as genetic predispo-
sitions, comorbidities, competing addictions and
lifestyle factors not considered due to a lack of
information.
▪ A limitation is that the results were based on
self-reporting since patients are likely to overesti-
mate their success; we assumed that overestima-
tions were evenly distributed and that the groups
were thus comparable in spite of potentially
slightly overestimated quit rates.
▪ Owing to varying cultural traditions, smoking
habits and socioeconomic conditions, generali-
sations should be considered carefully.
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and policy measures have been implemented, including
smoking bans, higher tobacco taxes, and restrictions on
tobacco sales and advertising. Recently, Denmark signed
on to the WHO’s goal to reduce smoking by 30% by
2025,5 and speciﬁc regions are working towards imple-
menting a tobacco endgame.6 Furthermore, there are
many other resources to help smokers quit, such as a
quit line, national campaigns, training materials and
recently, aid based on information technology tools.
These efforts have contributed to an overall change in
smoking climates and attitudes. In Denmark, smoking
prevalence has declined by 0.5–1 percentage point per
annum during the past decade. In 2013, 17% of the
Danish population over 15 years of age smoked daily,
and an additional 6% smoked occasionally.7
Since 1995, the Gold Standard Programme (GSP) has
become routine in Denmark, and the vast majority of
smoking cessation interventions offered are the GSP.8 It
is a comprehensive intervention comprising ﬁve meet-
ings over 6 weeks and fulﬁlling intensive clinical inter-
vention requirements.9 Programme counsellors are
specially trained to provide this manual-based patient
education programme. Smokers are either referred to
the intervention by health practitioners, or they can
contact programme providers themselves. The GSP has
proven to be highly effective and cost-effective, even
across subgroups,10–15 but its effectiveness has not yet
been compared with that of other programmes. In add-
ition to the GSP, other face-to-face methods (eg, crash
courses, health promotion counselling, alternative treat-
ments and Come & Quit programmes) have been used
and evaluated through the national Danish Smoking
Cessation Database (SCDB). The aim of this study was to
compare the effectiveness of the GSP with the effective-
ness of other face-to-face smoking cessation programmes
used in Denmark. The main hypothesis was that the
GSP would be the most effective intervention after
6 months. We also aimed to identify factors associated
with successful smoking cessation.
METHODS
Study design
This prospective cohort study on the SCDB included
patients treated from 2001 to 2013 with follow-up until
2014. The SCDB lists ∼80–90% of all clinics performing
face-to-face interventions used in Denmark,16 and we
thus consider this a representative sample.
Setting
During the study, 423 smoking cessation clinics reported
data from municipal clinics, pharmacies, hospitals, mid-
wives, primary care facilities and other private providers.
Smokers could attend smoking cessation interventions
free of charge with or without referrals. Approximately
10% attended an intervention at a private provider with
payment. From 2001 to 2005, this proportion was 19%,
and from 2006 to 2012, it was 4%, likely due to structural
changes made in the Danish healthcare system.16
Intervention
Different real-life smoking cessation interventions were
identiﬁed and compared with the data registered in the
SCDB (ﬁgure 1).
In accordance with the guidelines, patients who
attended at least 75% of the scheduled meetings were
considered compliant.17 For Come & Quit18 (ﬁgure 1),
four meetings corresponded to 75% of the GSP.8
Participants
In 2001–2013, 82 515 smokers were registered in the
SCDB after providing informed consent (see ﬁgure 2).
Inclusion criteria: Patients ≥15 years old at the begin-
ning of the programme who attended a smoking cessa-
tion programme with planned follow-up.
Exclusion criteria: Patients <15 years; patients not
wanting to be contacted after 6 months; patients who
were intentionally not followed up because the smoking
cessation clinic decided beforehand not to; and patients
without information on which intervention they
received.
In total, 46 287 smokers who were followed up for
6 months were included (ﬁgure 2). Of them, 26% were
lost to follow-up because they did not respond or
because their smoking status was missing. The remaining
34 235 patients were included in the outcome analyses.
Overall, 82 387 patients were included in the non-
respondent analyses.
Data
We used data from the SCDB.8 The database was estab-
lished in 2000 as a research database. The SCDB is avail-
able to all providers of smoking cessation intervention,
and it is free of charge. Data are reported to the SCDB
using standardised questionnaires on smoking histories,
sociodemographic characteristics, treatments and
follow-up.
Beginning in 2006, minor adjustments were made to
the questionnaires and follow-up procedures. No valid-
ation of self-reported smoking status was required.8
Follow-up was 6 months after the scheduled quit date or,
secondarily, the date of course completion. From 2001
to 2005, the information was collected by mail or tele-
phone, and at least one reminder was required. For
2006 and later, the data were collected by telephone
exclusively. After four attempts to reach the patient, of
which at least one was made in the evening, the patient
was reported as a non-respondent.
Outcomes
Primary outcome
Continuous abstinence for 6 months, deﬁned as not
smoking from the intended quit date (or previous treat-
ment date) to the 6-month follow-up ±1 month.
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Other variables
Factors associated with a positive outcome were studied
after controlling for interventions, the time of collection,
age, disadvantaged patients, heavy smoking, compliance,
living with a smoker, setting, geographic region, pro-
gramme format and medication offered for free.
Most variables were collected in categories. Age, daily
tobacco consumption data (grams/day) and Fagerström
scores on nicotine dependency (from 0 to 10 points)19
were collected as continuous data. The data were cate-
gorised as shown in table 1.
Data on GPS and other interventions were available
throughout the study period, but data on crash courses
were only provided before 2006. Finally, Come & Quit
data were recorded from 2011.
A low education level was deﬁned as no education ex-
cept primary school or short work-related courses.13
Unemployment meant without a job, on sick leave or
receiving compensation (in contrast to everyone else,
including employees, students/patients under education,
retirees and parents on maternity/paternity leave).13
Patients were deﬁned as disadvantaged if they had
been unemployed or had a low level of education.13
Heavy smokers were deﬁned as follows: ≥20 pack-years,
smoking ≥20 g of tobacco/day or reaching ≥7 points on
the Fagerström score.12 19
Figure 1 Descriptions of
smoking cessation interventions
examined in this study. GSP,
Gold Standard Programme;
SCDB, Smoking Cessation
Database.
Figure 2 Flow chart. In total,
82 515 smokers were registered
in the SCDB and 36 228 were
excluded, leaving 46 287 smokers
in the study population. Of them,
26% of the study population were
lost to follow-up, leaving 34 235
smokers included in the outcome
analyses. SCDB, Smoking
Cessation Database.
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Table 1 Characteristics of the 46 287 included smokers by intervention type
GSP
Health promotion
counselling Crash courses Come & Quit Other
n (%) n (%) n (%) n (%) n (%)
Total* 40 651 (100) 140 (100) 183 (100) 1592 (100) 3721 (100)
Time for data collection
2001 1341 (3.3) − 37 (20.2) − 172 (4.6)
2002–2003 6221 (15.3) − 109 (59.6) − 814 (21.9)
2004–2005 7933 (19.5) − 37 (20.2) − 529 (14.2)
2006–2007 7747 (19.1) 1 (0.7) − − 415 (11.2)
2008–2009 8062 (19.8) 42 (30.0) − − 618 (16.6)
2010–2011 5772 (14.2) 46 (32.9) − 211 (13.3) 550 (14.8)
2012–2013 3575 (8.8) 51 (36.4) − 1381 (86.8) 623 (16.7)
Participants
Sex
Men 15 655 (38.5) 71 (50.7) 75 (41.0) 638 (40.1) 1532 (41.2)
Women 24 992 (61.5) 69 (49.3) 108 (59.0) 954 (59.9) 2186 (58.8)
Age (years)
15–24 years 1892 (4.7) 7 (5.0) 6 (3.3) 118 (7.4) 335 (9.0)
25–34 years 5173 (12.7) 25 (17.9) 24 (13.1) 140 (8.8) 523 (14.1)
35–44 years 8471 (20.8) 28 (20.0) 34 (18.6) 225 (14.1) 772 (20.8)
45–54 years 10 985 (27.0) 19 (13.6) 51 (27.9) 395 (24.8) 860 (23.1)
55+ years 14 031 (34.5) 61 (43.6) 68 (37.2) 714 (44.9) 1213 (32.6)
Education
Low level 20 764 (51.1) 40 (28.6) 168 (91.8) 521 (32.7) 2084 (56.0)
High level 18 425 (45.3) 96 (68.6) 12 (6.6) 1024 (64.3) 1429 (38.4)
Employment
Unemployed 6885 (16.9) 32 (22.9) 31 (16.9) 522 (32.8) 830 (22.3)
Not unemployed 32 750 (80.6) 106 (75.7) 146 (79.8) 1035 (65.0) 2779 (74.7)
Disadvantaged smokers (by work situation and education)
Yes 23 654 (58.2) 55 (39.3) 172 (94.0) 825 (51.8) 2417 (65.0)
No 15 526 (38.2) 82 (58.6) 9 (4.9) 729 (45.8) 1113 (29.9)
Smoking
<20 pack-years 13 615 (33.5) 48 (34.3) 56 (30.6) 507 (31.9) 1391 (37.4)
≥20 pack-years 26 368 (64.9) 91 (65.0) 119 (65.0) 1063 (66.8) 2274 (61.1)
Fagerström 1–6 points 29 264 (72.0) 102 (72.9) 124 (67.8) 1139 (71.6) 2600 (69.9)
Fagerström 7–10 points 11 142 (27.4) 38 (27.1) 56 (30.6) 445 (28.0) 1093 (29.4)
<20 cigarettes per day 17 230 (42.4) 53 (37.9) 82 (44.8) 725 (45.5) 1528 (41.1)
≥20 cigarettes per day 22 950 (56.5) 87 (62.1) 96 (52.5) 867 (54.5) 2155 (57.9)
Heavy smokers (based on pack-years, Fagerström scores and daily consumption levels)
No 9845 (24.2) 30 (21.4) 46 (25.1) 356 (22.4) 988 (26.6)
Yes 30 591 (75.3) 109 (77.9) 135 (73.8) 1213 (76.2) 2711 (72.9)
Compliance with programme (based on attendance)
Not compliant 14 479 (35.6) 44 (31.4) 1 (0.6) 691 (43.4) 1064 (28.6)
Compliant 25 731 (63.3) 89 (63.6) 182 (99.4) 825 (51.8) 2470 (66.4)
Living with a smoker
No 25 802 (63.5) 101 (72.1) 120 (65.6) 1117 (70.2) 2316 (62.2)
Yes 14 410 (35.5) 38 (27.1) 61 (33.3) 451 (28.3) 1358 (36.5)
Living with others†
Living alone 8754 (21.5) 52 (37.1) − 656 (41.2) 744 (20.0)
Living with children (±adults) 7717 (19.0) 38 (27.1) − 365 (22.9) 744 (20.0)
Living with adults (no children) 8436 (20.8) 49 (35.0) − 543 (34.1) 692 (18.6)
Housing situation†
Residential property 11 811 (29.1) 63 (45.0) − 556 (34.9) 844 (22.7)
Cooperative dwelling 2172 (5.3) 6 (4.3) − 139 (8.7) 184 (4.9)
Rented accommodation 10 464 (25.7) 64 (45.7) − 828 (52.0) 1070 (28.8)
Other housing 248 (0.6) 4 (2.9) − 34 (2.1) 62 (1.7)
Referral
No 16 509 (40.6) 35 (25.0) 82 (44.8) 459 (28.8) 1544 (41.5)
Yes, from healthcare personal 18 927 (46.6) 100 (71.4) 53 (29.0) 1069 (67.2) 1770 (47.6)
Continued
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Statistical analyses
Results are reported as absolute numbers and percen-
tages, including missing data, loss to follow-up and
non-respondent analyses according to the RECORD
guidelines20 for population and clinical databases (base
case). To compare these data to randomised controlled
trials, the results were also reported according to the
Russell Standards,21 whereby non-respondents were
presumed to have relapsed (worst case).
ORs were estimated using logistic regression analyses
for men and women separately to test for differences in
continuous abstinence levels. Initial analyses included
selected prognostic factors from table 1 adjusted for sex
and age. Hereafter, the multivariable mixed-effect
regression model for clustered data was ﬁtted, and pre-
dictors were included based on the initial analyses and
established knowledge. The ﬁnal analyses were adjusted
for the time of data collection, geographic regions, age,
Table 1 Continued
GSP
Health promotion
counselling Crash courses Come & Quit Other
n (%) n (%) n (%) n (%) n (%)
Yes, from others 4047 (10.0) − 48 (26.2) − 305 (8.2)
Attempts to quit
No previous attempts 12 258 (30.2) 55 (39.3) 38 (20.8) 565 (35.5) 1121 (30.1)
1–3 previous attempts 20 605 (50.7) 74 (52.9) 85 (46.5) 813 (51.1) 1835 (49.3)
>3 previous attempts 5526 (13.6) 11 (7.9) 38 (20.8) 178 (11.2) 543 (14.6)
Yes unknown number of
attempts
1397 (3.4) − 20 (10.9) − 137 (3.7)
Smoking cessation clinic
Setting
Publicly oriented‡ 31 008 (76.3) 91 (65.0) 97 (53.0) 1592 (100) 1780 (47.8)
Hospital (including midwives) 8198 (20.2) 17 (12.1) 82 (44.8) 0 1415 (38.0)
Other 1445 (3.6) 32 (22.9) 4 (2.2) 0 526 (14.1)
Geographic area
Capital Region of Denmark 13 353 (32.9) 23 (16.4) 69 (37.7) 368 (23.1) 1845 (49.6)
Region Zealand 5856 (14.4) 4 (2.9) 78 (42.6) 131 (8.2) 248 (6.7)
Region of Southern Denmark 10 378 (25.5) 27 (19.3) 17 (9.3) 318 (20.0) 601 (16.2)
Central Denmark Region 9237 (22.7) 80 (57.1) 16 (8.7) 569 (35.7) 868 (23.3)
North Denmark Region 1827 (4.5) 6 (4.3) 3 (1.6) 206 (12.9) 159 (4.3)
Smoking cessation intervention
Programme format
Individual 5878 (14.5) 127 (90.7) 28 (15.3) 166 (10.4) 1707 (45.9)
Group 34 773 (85.5) 13 (9.3) 155 (84.7) 1426 (89.6) 2014 (54.1)
Target audience
Patients and relations 3647 (9.0) 31 (22.1) 20 (10.9) 44 (2.8) 978 (26.3)
Employees (workplace course) 10 060 (24.8) 4 (2.9) 44 (24.0) 76 (4.8) 649 (17.4)
Ordinary citizens 22 132 (54.4) 71 (50.7) 107 (58.5) 1259 (79.1) 1386 (37.3)
Mixed 2516 (6.2) 1 (0.7) 6 (3.3) 76 (4.8) 84 (2.3)
Pregnant women (and
partners)
1156 (2.8) 2 (1.4) 4 (2.2) 4 (0.3) 80 (2.2)
Other 1125 (2.8) 31 (22.1) 2 (1.1) 133 (8.4) 543 (14.6)
Medication offered for free
No free medication 15 324 (37.7) 120 (85.7) 60 (32.8) 1342 (84.3) 1641 (44.1)
Free for days (<1 week) 17 367 (42.7) 8 (5.7) 97 (53.0) 39 (2.5) 880 (23.7)
Free for ≥1 week 4843 (11.9) 12 (8.6) 26 (14.2) 205 (12.9) 976 (26.2)
Counselling free of charge
Yes 36 544 (89.9) 137 (97.9) 183 (100) 1589 (99.8) 3318 (89.2)
No 4066 (10.0) 3 (2.1) 0 0 400 (10.8)
Planned relapse prevention†
No 13 413 (33.0) 58 (41.4) − 945 (59.4) 898 (24.1)
Yes 11 751 (28.9) 82 (58.6) − 647 (40.6) 1308 (35.2)
Dashes indicate that the variable was not measured
*Owing to missing values, not all variables add up to the total number (and 100%).
†Data obtained from 2006 and to the present.
‡Covers interventions in the municipalities and pharmacies.
GSP, Gold Standard Programme.
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being a disadvantaged smoker, heavy smoking, compli-
ance, living with a smoker, setting, individual or group
format, and supportive medication offered for free, and
all predictors were entered together. Patients with
missing values were excluded from the analyses. A multi-
variable analysis was also performed for all patients
together to obtain the OR for women compared with
that for men. Statistically signiﬁcant predictors of con-
tinuous abstinence were identiﬁed. The results are dis-
played as OR values and as corresponding 95% CIs.
Non-respondent analyses were performed using a χ2 test
to compare respondents with non-respondents; compli-
ant patients with non-compliant patients and patients
who were intentionally not followed up with followed up
patients according to the characteristics listed in table 1.
A two-sided p value of <0.05 was considered statistically
signiﬁcant. All statistical calculations were performed
using Stata/IC V.14 (StataCorp LP).
Data access and cleaning
In this study, we had full access to the entire SCDB
population. All Civil Registration System (CPR) numbers
(CPR; a unique 10-digit number including the date of
birth and sex assigned to every Dane at birth or to immi-
grants) were checked according to ofﬁcial validation
rules. Invalid CPRs were corrected according to the Civil
Registration System.22 Age and sex were corrected
accordingly.
Data from 2001 to 2005 were checked manually prior
to registration. Questionnaires with missing or invalid
data were returned to the smoking cessation units with
instructions on how to correct the data. In 2006, data
validation rules were established in the online registra-
tion application. Dates were validated to avoid non-
excising dates, and rules were applied to ensure that
required data were entered.
Multiple quit attempts
It was possible for patients to enrol repeatedly and to
thereby be registered in the database with two (or more)
different entries specifying the intervention, baseline
data and a follow-up for each intervention.
Owing to the collection of the CPR, it was possible to
identify patients who had multiple interventions from
2006 to 2013. Before 2006, this was not possible. Patients
participating in multiple interventions were therefore
not excluded from either period.
The extent of duplicates for the 29 102 patients from
2006 to 2013 was 1607 corresponding to 6.6% of the
entries. We assumed that this value was similar before
2006 and take this into account in our interpretation of
the ﬁndings.
RESULTS
This study initially included 46 287 patients. Subsequently
12 052 (26%) patients were lost to follow-up, and 34 235
patients were included in the analyses. This number of
missing values was considered small (0–5%), except for
free supportive medication, which was 7.2%. The
characteristics are given in table 1.
Overall, 33% (11 184) of the responding patients
reported being continuously abstinent after 6 months. If
the non-respondents were considered to be smokers,
this proportion was 24%. Crude quit rates by interven-
tion type and sex are shown in table 2.
Predictors of abstinence
In the fully adjusted model, women were signiﬁcantly less
likely to remain abstinent than men (17% (OR=0.83,
95% CI 0.79 to 0.87)).
The GSP was the only intervention to present signiﬁ-
cant outcomes for men and women (table 3).
Though applying to very few patients, health promo-
tion counselling seemed to be the most effective inter-
vention for men (OR=2.64; 1.21 to 5.72), followed by
the GSP (OR=1.69; 1.27 to 2.24) and other interventions
(OR=1.50; 1.09 to 2.06). The effect of crash courses was
not signiﬁcant for men. For women, only the GSP
increased the effect signiﬁcantly (OR=1.31; 1.03 to
1.68).
For men and women, programme compliance was the
most pronounced predictor of success, and more
advanced age and not being disadvantaged or a heavy
smoker were other predictors (see table 3).
An effect of the time of data collection was present,
and the likelihood of remaining continuously abstinent
for 6 months was slightly higher at the start of the data
collection period (data not shown).
Table 2 Continuous abstinence after 6 months by smoking cessation intervention not adjusted for participant characteristics
Base case (RECORD criteria20) Worst case (Russell criteria21)
All Men Women All Men Women
Smoking cessation intervention n Per cent Per cent Per cent n Per cent Per cent Per cent
Come & Quit 960 22.5 21.7 23.0 1592 13.6 14.1 13.3
Gold Standard Programme 30 400 32.8 35.0 31.5 40 651 24.5 26.1 23.6
Health promotion counselling 71 32.9 47.4 17.1 140 17.1 25.4 8.7
Crash courses 159 27.7 36.4 21.5 183 24.0 32.0 18.5
Other 2645 34.8 35.9 34.1 3721 24.8 25.3 24.4
The worst case counted the non-respondents as smokers.
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Non-respondent analyses
We performed a non-respondent analysis of the 46 287
smokers included in the study by comparing respondents
(34 235 smokers) with non-respondents (12 052 smokers
lost to follow-up). Respondents and non-respondents
were signiﬁcantly different in regard to every variable
tested (see online supplementary appendix). The largest
difference between the two groups (16.8 percentage
points) was seen in regard to compliance, where the
smokers lost to follow-up were less likely to be compliant
with the programme. In addition, time of data collection,
age, education, employment, pack-years, housing situ-
ation, setting, geographic area and planned relapse pre-
vention differed by more than 5 percentage points.
Table 3 Explanatory variables included in the final multivariable logistic regression analyses.
Multivariable analyses
OR (95% CI)
Multivariable analyses
OR (95% CI) Interaction with sex
Men n=11 724 Women n=18 184 p Value
Smoking cessation intervention
Come & Quit 1 1
Gold Standard Programme 1.69 (1.27 to 2.24) 1.31 (1.03 to 1.68) 0.079
Health promotion counselling 2.64 (1.21 to 5.72) 0.48 (0.17 to 1.34) 0.013*
Crash courses 1.08 (0.58 to 2.02) 0.49 (0.28 to 0.87) 0.054
Other 1.50 (1.09 to 2.06) 1.20 (0.91 to 1.58) 0.244
Participants
Age (years)
15–24 years 1 1
25–34 years 1.22 (0.91 to 1.62) 1.29 (1.06 to 1.57) 0.918
35–44 years 1.37 (1.04 to 1.80) 1.28 (1.06 to 1.55) 0.413
45–54 years 1.49 (1.14 to 1.96) 1.31 (1.08 to 1.57) 0.193
55+ years 1.48 (1.13 to 1.94) 1.35 (1.12 to 1.63) 0.337
Disadvantaged smokers†
No 1 1
Yes 0.81 (0.73 to 0.89) 0.82 (0.76 to 0.89) 0.594
Heavy smokers‡
No 1 1
Yes 0.73 (0.65 to 0.81) 0.65 (0.60 to 0.70) 0.021*
Compliance with programme§
No 1 1
Yes 3.65 (3.29 to 4.04) 3.58 (3.30 to 3.89) 0.430
Living with a smoker
No 1 1
Yes 0.94 (0.86 to 1.02) 0.92 (0.86 to 0.99) 0.590
Smoking cessation clinic
Setting
Citizen aimed 1 1
Hospital (including midwives) 1.02 (0.85 to 1.21) 1.09 (0.94 to 1.27) 0.982
Other 1.13 (0.89 to 1.45) 1.05 (0.84 to 1.31) 0.191
Smoking cessation intervention
Programme format
Individual 1 1
Group 0.96 (0.84 to 1.10) 0.97 (0.87 to 1.08) 0.696
Medication offered for free
No free medication 1 1
Free for days (<1 week) 0.87 (0.78 to 0.97) 0.87 (0.80 to 0.96) 0.199
Free for ≥1 week 0.97 (0.82 to 1.14) 0.95 (0.83 to 1.10) 0.163
Hierarchical cluster Variance (95% CI) Variance (95% CI)
Smoking cessation clinic
Variance of random intercepts 0.06 (0.04 to 0.11) 0.07 (0.04 to 0.11)
In addition, the model was also adjusted for the time of data collection and for geographic regions. Statistically significant results are marked
with an *.
†Disadvantaged smokers: unemployed and receiving unemployment benefits and/or low education (no education except primary schooling
and/or only short work-related courses).13
‡Heavy smokers: smoking ≥20 pack-years and/or daily consumption of ≥20 cigarettes and/or Fagerström nicotine dependency score of ≥7
points.12 19
§Compliance with the programme was defined as having attended at least 75% of the scheduled meetings17 or for Come & Quit at least four
sessions.8
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Another analysis performed on 82 387 smokers com-
paring patients not wanting to be contacted or who were
intentionally not followed up (36 100 smokers) with
those who were (46 287 smokers) showed differences of
up to 8.4 percentage points (see online supplementary
appendix). The largest difference was geographic area,
but time of collection, and planned relapse prevention
also differed by more than 5 percentage points between
the compared groups.
DISCUSSION
Overall, every third GSP intervention resulted in a suc-
cessful outcome after 6 months. Compared with women,
men were more successful, with an additional one in six
patients being continuously abstinent. Only the GSP
showed a signiﬁcant result regardless of sex even after
adjusting for independent variables affecting the
outcomes.
Interestingly, the short interventions seemed to be
highly effective for men, while women halved their odds
of success following short interventions. For both sexes,
compliance, as well as advanced age and not being a dis-
advantaged or a heavy smoker were predictors of suc-
cessful quitting.
The high effectiveness of the GSP for men and
women in our study was also observed in randomised
and controlled trials evaluating the programme against
typical treatments.23 24 A review found intensive group
interventions to be the most effective compared with
other formats.25
Compliance was the most important predictor, increas-
ing the odds of abstinence more than 3.5-fold regardless
of sex. An earlier study showed a dose-dependent
response between compliance and continuous abstin-
ence for GSP; the more sessions attended, the greater
the chance of succeeding.17 It should be noted that
compliant patients included in our study had several
characteristics that were associated with high quit rates.
In line with other studies, we found that even though
women were more likely to attend a smoking cessation
intervention, they were signiﬁcantly less likely to succeed
than men.25 26 Bohadana et al27 also conﬁrmed these
ﬁndings, which could be explained by differences in
nicotine and behavioural dependence between women
and men. Other studies have found no differences in
regard to sex28 29 or that women are more likely to quit
smoking.30
Though only a few patients undertook short pro-
grammes, men showed more promising results, while
women showed signiﬁcantly worse results. Brief interven-
tions are generally recommended, though their overall
effect is low. In addition, the setting could be of rele-
vance, as a recent review found no effect of short inter-
ventions among surgical patients.31
Interestingly, offering free nicotine replacement
therapy (NRT) or other supportive medicine had a
negative effect on outcomes. The literature is
contradictory on this matter. A recent study from
England showed no effect of free NRT in combination
with a supportive quit line for patients who wanted to
quit.32 In contrast, another study found that offering
free NRT increased the chances of success signiﬁ-
cantly.33 A possible explanation could be the inﬂuence
of other non-individual variables, such as the type of
health system, local general dental practices or the avail-
ability of over-the-counter drugs. Further studies are
needed to clarify which group of smokers under which
conditions would beneﬁt from free NRT.
During the study period from 2001 to 2013, smoking
prevalence in Denmark dropped from 30% to 17% daily
smokers, corresponding to 1230–780 000 people. Over
this period, 82 431 smokers aged 15 years or older
received a face-to-face smoking cessation intervention
programme registered in the SCDB, corresponding to
∼7–11% of all daily smokers. Converted to a yearly basis,
fewer than 1% of the smokers in Denmark have received
a face-to-face smoking cessation intervention. This
number is very low compared with that of England,
where 5–10% of the smokers are treated by the Stop
Smoking Service,29 as well as compared with national
and international guidelines recommending that 5% of
all smokers should receive a smoking cessation interven-
tion yearly. It is difﬁcult to compare the present data to
other countries since, to the best of our knowledge, no
other countries have clinical registers with national
coverage.
This study has limitations as well as strengths. The
non-respondent analyses showed that the respondents
were more compliant, indicating that the respondents
were more likely to be continuously abstinent.
Therefore, the results based on the RECORD criteria
may overestimate the quit rate when extrapolated to
non-respondents. In contrast, the compliance of patients
with and without intended follow-up was more similar.
Some of the differences identiﬁed could be attributed to
the large sample size. The follow-up rate was relatively
high (74%), and the large number of patients from
across the country and across settings was a strength of
this study. Even though the coverage was high, the
SCDB may not cover all activities. However, only 3 of the
98 municipalities never reported to the database.
Smoking cessation intervention activities across regions
of Denmark differed more than the distribution of
smokers.34 Relatively, the North Denmark Region
treated fewer smokers, while the Capital Region of
Denmark treated more patients than expected based on
the number of smokers in each region. However, even
the most active region has treated only 0.6% of all
smokers annually which is far lower than the recom-
mended 5%.35 An additional strength was the low
amount of missing data. We addressed missing data
according to RECORD guidelines.20 Some of the pro-
grammes were only recorded in the database in a
limited part of the study period. Two of the programmes
only had a very low number of participants (0.3% and
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0.4%) and the inﬂuence on the overall result is there-
fore very limited. The programme Come & Quit was
established in 2011 but includes 3.4% of the smokers
and may potentially affect the comparative analyses.
However, time for data collection only showed a minor
reduction of successful quitting overtime. Thus, the
effect of the crash courses recorded only in the begin-
ning of the period may be slightly overestimated. We
also reported continuous abstinence as the primary
outcome, in contrast to point prevalence, which has
several limitations.36 The self-reporting was a limitation,
as patients are likely to overestimate their success by
3–6% compared with co-validated outcomes.37–39 We
had no reason to assume that this overestimation was
unevenly distributed among the different interventions.
Therefore, the groups should be comparable, even
though the quit rates may be slightly overestimated in
general. Owing to different cultural traditions, smoking
habits and socioeconomic conditions, generalisations
should be considered carefully. The implications of
using the routinely collected health data from the SCDB
in this study must be considered minimal, as the study is
in line with the purposes of the database. Only minor
changes in data collection took place over time to in-
clude new supportive medicine, and the eligibility has
changed over time due to changes in the Danish health-
care system.16 We consider the completeness and preci-
sion of the data to be high.8 We are not able to identify
possible misclassiﬁcations, but we expect their occurrence
to be very low. We are also aware of other potential con-
founders such as genetic predisposition, comorbidities,
competing addictions and lifestyle factors that are not
included in the analysis due to a lack of information.
From a societal perspective, it is highly interesting that
the GSP is effective across different socioeconomic
groups. A systematic implementation of the GSP would
therefore be highly effective among lower socio-
economic groups with the highest smoking prevalence.
Only by collecting nationwide data in a clinical database
such as the SCDB it is possible to document this import-
ant effect. Furthermore, free NRTs, other supportive
medications and self-payment counselling did not show
any association with the quit rate, in agreement with a
recent publication on ﬁnancial incentives for smoking
cessation.40
This study has raised a new hypothesis on the effective-
ness of short interventions among men that should be
investigated further.
Another area requiring further investigation is the
effectiveness of smoking cessation among groups with
very high smoking prevalence, such as mentally ill
patients. Recent research indicates that smoking is asso-
ciated with the development of psychosis because psych-
osis develops earlier and more frequently among
smokers than among non-smokers.41 The high preva-
lence of smoking among psychiatric patients has tradition-
ally been interpreted as a form of self-medication, but this
has now been questioned by a meta-analysis showing that
smoking cessation improves the mental conditions of
smokers with and without a psychiatric diagnosis.42
A ﬁnal area of major interest is that smoking cessation
databases can be used for early detection, that is, to
follow the effects of smoking cessation interventions
across a country rather than waiting to see the effect dir-
ectly on smoking-related illness and death. We recom-
mend that other countries establish national smoking
cessation databases for these purposes and for compar-
ing effects between countries.
CONCLUSION
Over time, Danish smoking cessation interventions have
been shown to be effective in real life. Ultimately, one in
three smokers are still abstinent at 6 months of follow-up
(or one in four if non-respondents are judged as
smokers). Compliance is the main predictor of success-
ful quitting. We expected to ﬁnd that the GSP would be
the most effective intervention, but interestingly, short
programmes also seem to have relatively strong effect
among men, though the absolute numbers are very
small. Only the comprehensive standard programme in
Denmark, the GSP, works across sexes.
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